Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel L Bravo

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Arquivos Brasileiros De Endocrinologia E Metabologia|March 12, 2005
Pheochromocytoma: current perspectives in the pathogenesis, diagnosis, and managementEmmanuel L Bravo
Current Hypertension Reports|March 19, 2003
Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular diseaseEmmanuel L Bravo
Annals of the New York Academy of Sciences|October 17, 2002
Pheochromocytoma: an approach to antihypertensive managementEmmanuel L Bravo
Cardiology in Review|January 16, 2002
PheochromocytomaEmmanuel L Bravo
Cleveland Clinic Journal of Medicine|March 14, 2002
What is the best diagnostic approach when pheochromocytoma is suspected?Emmanuel L Bravo
Endocrine Reviews|August 16, 2003
Pheochromocytoma: state-of-the-art and future prospectsEmmanuel L Bravo, Rodrigo Tagle
Journal of the American College of Cardiology|May 8, 2010
New insight into the role of aldosterone/renin ratio in elevated peripheral and central blood pressureEmmanuel L Bravo, Mohammed A Rafey
Clinical Journal of the American Society of Nephrology : CJASN|August 10, 2013
Aldosterone breakthrough during angiotensin receptor blocker use: more questions than answers?Sankar D Navaneethan, Emmanuel L Bravo
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2009
Renal denervation for resistant hypertensionEmmanuel L Bravo, Mohammed A Rafey, Joseph V Nally
Cleveland Clinic Journal of Medicine|July 4, 2012
Renal denervation to treat resistant hypertension: Guarded optimismGeorge Thomas, Mehdi H Shishehbor, Emmanuel L Bravo, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Arquivos Brasileiros De Endocrinologia E Metabologia|March 12, 2005
Pheochromocytoma: current perspectives in the pathogenesis, diagnosis, and managementEmmanuel L Bravo
Current Hypertension Reports|March 19, 2003
Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular diseaseEmmanuel L Bravo
Annals of the New York Academy of Sciences|October 17, 2002
Pheochromocytoma: an approach to antihypertensive managementEmmanuel L Bravo
Cardiology in Review|January 16, 2002
PheochromocytomaEmmanuel L Bravo
Cleveland Clinic Journal of Medicine|March 14, 2002
What is the best diagnostic approach when pheochromocytoma is suspected?Emmanuel L Bravo
Endocrine Reviews|August 16, 2003
Pheochromocytoma: state-of-the-art and future prospectsEmmanuel L Bravo, Rodrigo Tagle
Journal of the American College of Cardiology|May 8, 2010
New insight into the role of aldosterone/renin ratio in elevated peripheral and central blood pressureEmmanuel L Bravo, Mohammed A Rafey
Clinical Journal of the American Society of Nephrology : CJASN|August 10, 2013
Aldosterone breakthrough during angiotensin receptor blocker use: more questions than answers?Sankar D Navaneethan, Emmanuel L Bravo
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2009
Renal denervation for resistant hypertensionEmmanuel L Bravo, Mohammed A Rafey, Joseph V Nally
Cleveland Clinic Journal of Medicine|July 4, 2012
Renal denervation to treat resistant hypertension: Guarded optimismGeorge Thomas, Mehdi H Shishehbor, Emmanuel L Bravo, et al.
Pageof 2